Dr. Martens (LON:DOCS) Insider Giles Wilson Acquires 167 Shares

Dr. Martens plc (LON:DOCS) insider Giles Wilson bought 167 shares of Dr. Martens stock in a transaction that occurred on Monday, October 13th. The shares were acquired at an average price of GBX 89 per share, with a total value of £148.63.

Giles Wilson also recently made the following trade(s):

• On Wednesday, October 8th, Giles Wilson bought 114 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 90 per share, with a total value of £102.60.
• On Thursday, September 11th, Giles Wilson bought 167 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 90 per share, with a total value of £150.30.
• On Monday, September 1st, Giles Wilson bought 105,838 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 91 per share, with a total value of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The stock was sold at an average price of GBX 91, for a total transaction of £27,300.
• On Monday, September 1st, Giles Wilson bought 30,019 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 91 per share, with a total value of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total transaction of £95,206.50.
• On Monday, August 11th, Giles Wilson purchased 194 shares of Dr. Martens stock. The shares were purchased at an average cost of GBX 77 per share, for a total transaction of £149.38.

Dr. Martens Stock Performance

LON DOCS opened at GBX 89.05 on Wednesday. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The firm’s fifty day moving average price is GBX 88.71 and its two-hundred day moving average price is GBX 73.38. Dr. Martens plc has a 1 year low of GBX 43.02 and a 1 year high of GBX 100.87. The firm has a market capitalization of £859.93 million, a P/E ratio of 17,810.00, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Dr. Martens in a research report on Friday, July 11th. Peel Hunt raised shares of Dr. Martens to a “buy” rating in a research report on Monday, August 18th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Dr. Martens presently has an average rating of “Hold” and a consensus price target of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.